GlassScriptPhysician profile
Michael Walter Noble
NPI 1356331672
$17,391.55
in general payments reported to CMS, 2019-2025
14 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,175 · 2021: $449 · 2022: $921 · 2023: $974 · 2024: $475 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274 · Education: $271 · Entertainment: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.57 |
| Education | $270.59 |
| Entertainment | $239.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $12,500.00 | 2019 | |
| Keystone Dental INC. | $1,963.32 | 2020-2024 | |
| Straumann USA LLC | $988.78 | 2019-2025 | |
| Nobel Biocare USA | $693.22 | 2019-2023 | Nobelactive |
| Darby Dental Supply, LLC | $262.97 | 2022 | |
| Axogen | $248.16 | 2020-2025 | |
| Dentsply Sirona INC | $235.14 | 2020 | |
| Zimmer Biomet Holdings, INC. | $212.12 | 2021-2025 | Tmj System |
| Depuy Synthes Sales INC. | $91.17 | 2019 | |
| Geistlich Pharma, North America, INC. | $64.61 | 2019 | |
| Biohorizons Implant Systems INC. | $37.68 | 2021 | |
| Salvin Dental Specialties, INC. | $37.65 | 2019 | |
| Henry Schein, INC. | $37.60 | 2019 | |
| Dentsply Ih INC. | $19.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Noble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.